Caplin Point eye drops get FDA nod
Caplin Steriles, subsidiary of Caplin Point Laboratories, bags FDA nod for eye drops used to treat conjunctivitis, corneal ulcer16-04-2024
Caplin Point eye drops get FDA nod
Caplin Steriles, subsidiary of Caplin Point Laboratories, bags FDA nod for eye drops used to treat conjunctivitis, corneal ulcerCAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find the attached Press Release on USFDA approval for Ofloxacin Ophthalmic Solution ANDA.CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 is enclosed.CAPLIN POINT LABORATORIES LTD. - 524742 - Regulation 7(3) - Compliance Certificate For The Year Ended March 31, 2024
Compliance Certificate under Regulation 7(3) is enclosed herewith.CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window
The details regarding trading window closure for the year ending March 31, 2024 is attached herewith.Caplin Point's subsidiary receives FDA approval for generic eye drops, shares up 2.78%
Additionally, Caplin is working on a portfolio of 40+ simple and complex Injectable and Ophthalmic products, intending to file them over the next 4 yearsCAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release regarding grant of final from the USFDA for ANDA Ketorolac tromethamine Ophthalmic Solution 0.5% is attached herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Commencement Of Operations By Caplin One Labs Limited, Wos Of The Company
Press release regarding completion of state-of-art Oncology facility and commencement of operations by Caplin One Labs Limited, the WoS of the company is attached herewith